< Back to companies
Abridge

Abridge

The one conversation that matters.

Pittsburgh, PA, US

Abridge is an AI-powered platform that automatically generates structured clinical notes from patient-physician conversations. Using generative AI, it listens ambiently to the conversation and creates a real-time, accurate summary in the required format for the electronic health record (EHR), saving doctors hours of administrative work each day.

Hero image for Abridge
Note, this image was autogenerated by Syggy based on what we know about the company. It is not an official company publication.
Get Involved in Abridge

How We Help

Why it matters

Abridge addresses documentation burden, clinician burnout, note quality, and emerging revenue-cycle intelligence at the clinical conversation layer.

Products

📦

Abridge ambient AI platform

AI for clinical conversations and documentation across care settings.

Learn more →

What the company reports

Claims are attributed to their source and not independently verified unless noted.

  • Abridge announced a $150M Series C in February 2024.

    Company statessource →
  • Abridge announced a $300M Series E led by a16z in June 2025.

    Company statessource →
  • Abridge is recognized as Best in KLAS 2025 and 2026 for ambient AI.

    Company statessource →

Who it's for

CMIOChief Medical OfficerChief Digital OfficerCIOClinical Operations LeaderPhysiciansNursesAPPsClinical Documentation Teams

Founders

Via Digital.Health

Shivdev Rao, MD

Founder / CEO

Problem Statement

Physician burnout is a crisis, largely driven by the overwhelming burden of clinical documentation. Doctors spend more time on paperwork than with patients, leading to exhaustion, errors, and a decline in the quality of care. Existing solutions are often clunky and don't fit naturally into the patient-physician conversation.

Core Technology

Generative AI for Clinical Documentation

Key Differentiators

Focus on ambient, conversational AI that integrates seamlessly into the clinical workflow. Proprietary dataset from over 200,000 clinical encounters. Real-time note generation and structuring. Backed by major health systems and top-tier VCs.

Clinical Focus

Primary Care, Specialty Care

Target Customers

Hospitals, Health Systems, large physician groups.

Product Stage

GA

Company Info

Business Model
B2B2C
Founded
2018
Total Funding
212,500,000
Website
www.abridge.com/

Categories

Clinical Documentation AI

Disease Areas

Technologies

AIEHR IntegrationArtificial IntelligenceMachine LearningNatural Language ProcessingGenerative AISpeech Recognition

Clinical & IP

🔬

Clinical Validation

Abridge's technology is built on a proprietary dataset from more than 200,000 clinical encounters. Their AI is continuously trained and evaluated by medical professionals to ensure accuracy. They have demonstrated a 99%+ accuracy rate in identifying medical terms and medications. A study published in the New England Journal of Medicine Catalyst showed Abridge saved clinicians over 3 hours per week on average.

🛡️

IP Protection

Patents Pending

MedStartr Index Score

?
60

What do you think of Abridge?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Innovation

Clinical Benefit

Feasibility

Scalability

Get Involved in Abridge